SRSujan T. Reddy

Sujan T. Reddy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sujan T. Reddy has a total of 79 co-authors. Here are the top co-authors by number of shared publications:

  • Sean I. Savitz

    Institute for Stroke and Cerebrovascular Diseases McGovern Medical School University of Texas Health Science Center at Houston Texas USA

    5 shared publications
  • Christy Ankrom

    Department of Neurology, Institute for Stroke and Cerebrovascular Disease, University of Texas Health Science Center at Houston

    2 shared publications
  • Jing Zhang

    Department of Biostatistics and Data Science, University of Texas Health Science Center at Houston

    2 shared publications
  • Mohammad H. Rahbar

    Biostatistics/Epidemiology/Research Design Core Center for Clinical and Translational Sciences University of Texas Health Science Center at Houston Texas USA

    2 shared publications
  • Octavio Arevalo

    Louisiana State University Health Sciences Center Shreveport, Shreveport, USA

    2 shared publications
  • Tzu-Ching Wu

    Department of Neurology, Institute for Stroke and Cerebrovascular Disease, University of Texas Health Science Center at Houston

    2 shared publications

Latest Publications

  • Open Access

    A meta‐analysis of the global impact of the COVID‐19 pandemic on stroke care & the Houston Experience

    by Sujan T. Reddy, Nikunj Satani, Jennifer E. S. Beauchamp, Sudhakar Selvaraj, Suja S. Rajan, Mohammad H. Rahbar, Amirali Tahanan, Sori Kim, Travis Holder, Xiaoqian Jiang, et al.

    Objective: To review the global impact of the COVID‐19 pandemic on stroke care‐metrics and report data from a health system in Houston.Methods: We performed a meta‐analysis of the published literature reporting stroke admissions, intracerebral hemorrhage (ICH) cases, number of thrombolysis (tPA) and thrombectomy (MT) cases, and time metrics (door to needle, DTN; and door to groin time, DTG) during the pandemic compared to prepandemic period. Within our hospital system, between January–June 2019 and January–June 2020, we compared the proportion of stroke admissions and door to tPA and MT times.Results: A total of 32,640 stroke admissions from 29 studies were assessed. Compared to prepandemic period, the mean ratio of stroke admissions during the pandemic was 70.78% [95% CI, 65.02%, 76.54%], ICH cases was 83.10% [95% CI, 71.01%, 95.17%], tPA cases was 81.74% [95% CI, 72.33%, 91.16%], and MT cases was 88.63% [95% CI, 74.12%, 103.13%], whereas DTN time was 104.48% [95% CI, 95.52%, 113.44%] and DTG was 104.30% [95% CI, 81.99%, 126.61%].In Houston, a total of 4808 cases were assessed. There was an initial drop of ~30% in cases at the pandemic onset. Compared to 2019, there was a significant reduction in mild strokes (NIHSS 1‐5) [N (%), 891 (43) vs 635 (40), P = 0.02]. There were similar mean (SD) (mins) DTN [44 (17) vs 42 (17), P = 0.14] but significantly prolonged DTG times [94 (15) vs 85 (20), P = 0.005] in 2020.Interpretation: The COVID‐19 pandemic led to a global reduction in stroke admissions and treatment interventions and prolonged treatment time metrics.


  • Lack of Racial, Ethnic, and Sex Disparities in Ischemic Stroke Care Metrics within a Tele-Stroke Network

    by Sujan Reddy, Tzu-Ching Wu, Jing Zhang, Mohammad Hossein Rahbar, Christy Ankrom, Alicia Zha, Tc Cossey, Benjamin Aertker, Farhaan Vahidy, Kaushik Parsha, et al.


  • Rapid Infarct Progression in Anterior Circulation Large Vessel Occlusion Ischemic Stroke Patients During Inter-Facility Transfer

    by Sujan T. Reddy, Elliott Friedman, Tzu-Ching Wu, Octavio Arevalo, Jing Zhang, Mohammad H. Rahbar, Christy Ankrom, Hari Kishan Reddy Indupuru, Sean I. Savitz


  • Patients transferred within a telestroke network for large-vessel occlusion

    by Sujan T Reddy, Sean I Savitz, Elliott Friedman, Octavio Arevalo, Jing Zhang, Christy Ankrom, Alyssa Trevino, Tzu-Ching Wu

    Introduction: In a telestroke network, patients at a referring hospital (RH) with large-vessel occlusion (LVO) are transferred to a comprehensive stroke centre (CSC) for endovascular thrombectomy (EVT). However, a significant number of patients do not ultimately undergo thrombectomy after CSC arrival. Methods: Within a 17-hospital telestroke network, we retrospectively analysed patients with suspected or confirmed LVO transferred to a CSC, and characterized the reasons why these patients did not undergo EVT based on the 2019 American Heart Association guidelines. Results: Of 400 patients transferred to our hub, 68 (17%) were based on vascular imaging at RH. Time from RH arrival to neuroimaging was significantly longer in patients that underwent both computed tomography (CT) and CT angiography of the brain and neck compared to only CT of the brain (53 vs 13 minutes, p < 0.05). Accuracy of anterior circulation LVO (ACLVO) detection based on clinical suspicion was 62% (205 of 332 patients). Among 234 ACLVO patients, overall, 175 (74%) (early window group: 123 (73%) patients and late window group: 52 (80%) patients) met at least one EVT ineligibility criterion. The reasons for EVT ineligibility varied from large core infarct (aspects 70 cc on perfusion imaging in late window), low National Institutes of Health Stroke Scale (1). Discussion: Instituting rapid acquisition and interpretation of vascular imaging at RHs for LVO detection and establishing benchmarks for door to vascular imaging is urgently needed for RHs.


  • Open Access

    Hypertension-Related Cerebral Microbleeds

    by Sujan T. Reddy, Sean I. Savitz

    Hypertension and cerebral amyloid angiopathy are the most common causes of cerebral microbleeds. The pattern of microbleeds on T2*-weighted gradient echo sequence of magnetic resonance imaging of the brain can be indicative of the etiology of intracerebral hemorrhage. We describe a case of cerebellar hemorrhage with cerebral microbleeds secondary to chronic hypertension.


  • Open Access

    Cerebrovascular Disease in Patients with COVID-19: A Review of the Literature and Case Series

    by Sujan T. Reddy, Tanu Garg, Chintan Shah, Fábio A. Nascimento, Rajeel Imran, Peter Kan, Ritvij Bowry, Nicole Gonzales, Andrew Barreto, Abhay Kumar, et al.

    COVID-19 has been associated with a hypercoagulable state causing cardiovascular and neurovascular complications. To further characterize cerebrovascular disease (CVD) in COVID-19, we review the current literature of published cases and additionally report the clinical presentation, laboratory and diagnostic testing results of 12 cases with COVID-19 infection and concurrent CVD from two academic medical centers in Houston, TX, USA, between March 1 and May 10, 2020. To date, there are 12 case studies reporting 47 cases of CVD in COVID-19. However, only 4 small case series have described the clinical and laboratory findings in patients with COVID-19 and concurrent stroke. Viral neurotropism, endothelial dysfunction, coagulopathy and inflammation are plausible proposed mechanisms of CVD in COVID-19 patients. In our case series of 12 patients, 10 patients had an ischemic stroke, of which 1 suffered hemorrhagic transformation and two had intracerebral hemorrhage. Etiology was determined to be embolic without a clear cause identified in 6 ischemic stroke patients, while the remaining had an identifiable source of stroke. The majority of the patients had elevated inflammatory markers such as D-dimer and interleukin-6. In patients with embolic stroke of unclear etiology, COVID-19 may have played a direct or indirect role in the processes that eventually led to the strokes while in the remaining cases, it is unclear if infection contributed partially or was an incidental finding.


  • Atypical Cause of “Typical” Hypertensive Intracranial Bleeding

    by Sujan T. Reddy, David Rosenbaum, Sunil A. Sheth

    A man in his 50s with no known medical history presented with acute left hemiplegia. Noncontrast computed tomography of the head revealed right putamenal and intraventricular hemorrhage (Figure, A). Blood pressure at presentation was 211/100 mm Hg, without evidence of chronic hypertension on echocardiogram or electrocardiogram. Computed tomography angiography of the brain revealed occlusion of the right middle cerebral artery (MCA) with abnormal surrounding vasculature. Digital subtraction angiography demonstrated proximal MCA occlusion with dysplastic lenticulostriate branches serving as bypass to the distal-M1 MCA segment (Figure, B), suggesting that the cause of the hemorrhage was dysplastic vessel rupture. He was treated with blood pressure reduction medication, and an MCA bypass was planned to reduce flow in the dysplastic vessels.

  • Non-Vitamin K Oral Anticoagulants (NOACs) and Their Reversal

    by Sujan T. Reddy, Tc Cossey, Sean I. Savitz, James C. Grotta

    An 80-year-old man presents with an acute right hemiparesis and National Institutes of Health Stroke Scale (NIHSS) of 25, 14 h after taking dabigatran. Activated partial thromboplastin time (aPTT) is 42.8 s. Arteriogram demonstrates left internal carotid artery thrombosis. What is the appropriate management of this patient with acute ischemic stroke while on a NOAC?


  • Open Access

    Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study

    by Yong Qin, Mariana Petaccia de Macedo, Alexandre Reuben, Marie-Andrée Forget, Cara Haymaker, Chantale Bernatchez, Christine N. Spencer, Vancheswaran Gopalakrishnan, Sujan Reddy, Zachary A. Cooper, et al.

    The low response rates to immunotherapy in uveal melanoma (UM) sharply contrast with reputable response rates in cutaneous melanoma (CM) patients. To characterize the mechanisms responsible for resistance to immunotherapy in UM, we performed immune profiling in tumors from 10 metastatic UM patients and 10 metastatic CM patients by immunohistochemistry (IHC). Although there is no difference in infiltrating CD8+ T cells between UM and CM, a significant decrease in programmed death-1 (PD-1)-positive lymphocytes was observed and lower levels of programmed death ligand-1 (PD-L1) in UM metastases compared with CM metastases. Tumors from metastatic UM patients showed a lower success rate of tumor-infiltrating lymphocyte (TIL) growth compared with metastatic CM (45% vs. 64% success), with a significantly lower quantity of UM TIL expanded overall. These studies suggest that UM and CM are immunologically distinct, and provide potential explanation for the impaired success of immunotherapy in UM.